The Eversense 365 implant features a small sensor ... “The approval of Eversense 365 represents a significant leap in CGM ...
The implant is around the length and thickness of ... clearance for the first over the counter (OTC) CGM in June 2024. Dexcom is the CGM market leader in the US with 74% of the market share ...
Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.